Gene Page: ASH1L
Summary ?
GeneID | 55870 |
Symbol | ASH1L |
Synonyms | ASH1|ASH1L1|KMT2H |
Description | ash1 (absent, small, or homeotic)-like (Drosophila) |
Reference | MIM:607999|HGNC:HGNC:19088|Ensembl:ENSG00000116539|HPRD:06416|Vega:OTTHUMG00000014011 |
Gene type | protein-coding |
Map location | 1q22 |
Fetal beta | 0.681 |
eGene | Meta |
Support | CompositeSet Darnell FMRP targets Chromatin Remodeling Genes |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DNM:Fromer_2014 | Whole Exome Sequencing analysis | This study reported a WES study of 623 schizophrenia trios, reporting DNMs using genomic DNA. | |
GSMA_I | Genome scan meta-analysis | Psr: 0.0235 | |
GSMA_IIA | Genome scan meta-analysis (All samples) | Psr: 0.00814 | |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 1 |
Section I. Genetics and epigenetics annotation
DNM table
Gene | Chromosome | Position | Ref | Alt | Transcript | AA change | Mutation type | Sift | CG46 | Trait | Study |
---|---|---|---|---|---|---|---|---|---|---|---|
ASH1L | chr1 | 155452170 | C | T | NM_018489 | p.164R>H | missense | Schizophrenia | DNM:Fromer_2014 |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0003677 | DNA binding | IEA | - | |
GO:0003702 | RNA polymerase II transcription factor activity | TAS | 10860993 | |
GO:0005515 | protein binding | IEA | - | |
GO:0016740 | transferase activity | IEA | - | |
GO:0008270 | zinc ion binding | IEA | - | |
GO:0008168 | methyltransferase activity | IEA | - | |
GO:0018024 | histone-lysine N-methyltransferase activity | IEA | - | |
GO:0046872 | metal ion binding | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0006323 | DNA packaging | TAS | 10860993 | |
GO:0006355 | regulation of transcription, DNA-dependent | IEA | - | |
GO:0006350 | transcription | IEA | - | |
GO:0006366 | transcription from RNA polymerase II promoter | TAS | 10860993 | |
GO:0007267 | cell-cell signaling | TAS | 10860993 | |
GO:0016568 | chromatin modification | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005923 | tight junction | TAS | Brain (GO term level: 10) | 10860993 |
GO:0005794 | Golgi apparatus | IDA | 18029348 | |
GO:0005634 | nucleus | TAS | 10860993 | |
GO:0005737 | cytoplasm | IDA | 18029348 | |
GO:0030054 | cell junction | IEA | - |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG LYSINE DEGRADATION | 44 | 29 | All SZGR 2.0 genes in this pathway |
KEGG TIGHT JUNCTION | 134 | 86 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS BASAL UP | 380 | 215 | All SZGR 2.0 genes in this pathway |
SENESE HDAC3 TARGETS UP | 501 | 327 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781 | 1082 | All SZGR 2.0 genes in this pathway |
MOTAMED RESPONSE TO ANDROGEN DN | 6 | 5 | All SZGR 2.0 genes in this pathway |
PEREZ TP53 TARGETS | 1174 | 695 | All SZGR 2.0 genes in this pathway |
RASHI RESPONSE TO IONIZING RADIATION 6 | 84 | 54 | All SZGR 2.0 genes in this pathway |
KOYAMA SEMA3B TARGETS DN | 411 | 249 | All SZGR 2.0 genes in this pathway |
PARK HSC MARKERS | 44 | 31 | All SZGR 2.0 genes in this pathway |
MOREAUX MULTIPLE MYELOMA BY TACI UP | 412 | 249 | All SZGR 2.0 genes in this pathway |
CUI TCF21 TARGETS 2 DN | 830 | 547 | All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS STEM CELL | 254 | 164 | All SZGR 2.0 genes in this pathway |
BILD SRC ONCOGENIC SIGNATURE | 62 | 38 | All SZGR 2.0 genes in this pathway |
BILD CTNNB1 ONCOGENIC SIGNATURE | 82 | 52 | All SZGR 2.0 genes in this pathway |
DOUGLAS BMI1 TARGETS UP | 566 | 371 | All SZGR 2.0 genes in this pathway |
MARSON BOUND BY FOXP3 STIMULATED | 1022 | 619 | All SZGR 2.0 genes in this pathway |
ZHANG TLX TARGETS 36HR DN | 185 | 116 | All SZGR 2.0 genes in this pathway |
ROME INSULIN TARGETS IN MUSCLE UP | 442 | 263 | All SZGR 2.0 genes in this pathway |
WONG ADULT TISSUE STEM MODULE | 721 | 492 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-1/206 | 1470 | 1476 | 1A | hsa-miR-1 | UGGAAUGUAAAGAAGUAUGUA |
hsa-miR-206SZ | UGGAAUGUAAGGAAGUGUGUGG | ||||
hsa-miR-613 | AGGAAUGUUCCUUCUUUGCC | ||||
miR-101 | 1633 | 1639 | 1A | hsa-miR-101 | UACAGUACUGUGAUAACUGAAG |
miR-103/107 | 2223 | 2229 | m8 | hsa-miR-103brain | AGCAGCAUUGUACAGGGCUAUGA |
hsa-miR-107brain | AGCAGCAUUGUACAGGGCUAUCA | ||||
miR-129-5p | 2020 | 2026 | m8 | hsa-miR-129brain | CUUUUUGCGGUCUGGGCUUGC |
hsa-miR-129-5p | CUUUUUGCGGUCUGGGCUUGCU | ||||
miR-133 | 1388 | 1394 | 1A | hsa-miR-133a | UUGGUCCCCUUCAACCAGCUGU |
hsa-miR-133b | UUGGUCCCCUUCAACCAGCUA | ||||
miR-137 | 1342 | 1349 | 1A,m8 | hsa-miR-137 | UAUUGCUUAAGAAUACGCGUAG |
miR-139 | 1634 | 1641 | 1A,m8 | hsa-miR-139brain | UCUACAGUGCACGUGUCU |
miR-141/200a | 1856 | 1862 | 1A | hsa-miR-141 | UAACACUGUCUGGUAAAGAUGG |
hsa-miR-200a | UAACACUGUCUGGUAACGAUGU | ||||
miR-142-3p | 1932 | 1938 | m8 | hsa-miR-142-3p | UGUAGUGUUUCCUACUUUAUGGA |
hsa-miR-142-3p | UGUAGUGUUUCCUACUUUAUGGA | ||||
miR-143 | 2344 | 2350 | 1A | hsa-miR-143brain | UGAGAUGAAGCACUGUAGCUCA |
miR-144 | 1125 | 1131 | m8 | hsa-miR-144 | UACAGUAUAGAUGAUGUACUAG |
hsa-miR-144 | UACAGUAUAGAUGAUGUACUAG | ||||
miR-15/16/195/424/497 | 2224 | 2231 | 1A,m8 | hsa-miR-15abrain | UAGCAGCACAUAAUGGUUUGUG |
hsa-miR-16brain | UAGCAGCACGUAAAUAUUGGCG | ||||
hsa-miR-15bbrain | UAGCAGCACAUCAUGGUUUACA | ||||
hsa-miR-195SZ | UAGCAGCACAGAAAUAUUGGC | ||||
hsa-miR-424 | CAGCAGCAAUUCAUGUUUUGAA | ||||
hsa-miR-497 | CAGCAGCACACUGUGGUUUGU | ||||
miR-151 | 2360 | 2366 | m8 | hsa-miR-151brain | ACUAGACUGAAGCUCCUUGAGG |
miR-17-5p/20/93.mr/106/519.d | 1781 | 1787 | m8 | hsa-miR-17-5p | CAAAGUGCUUACAGUGCAGGUAGU |
hsa-miR-20abrain | UAAAGUGCUUAUAGUGCAGGUAG | ||||
hsa-miR-106a | AAAAGUGCUUACAGUGCAGGUAGC | ||||
hsa-miR-106bSZ | UAAAGUGCUGACAGUGCAGAU | ||||
hsa-miR-20bSZ | CAAAGUGCUCAUAGUGCAGGUAG | ||||
hsa-miR-519d | CAAAGUGCCUCCCUUUAGAGUGU | ||||
miR-203.1 | 1410 | 1416 | m8 | hsa-miR-203 | UGAAAUGUUUAGGACCACUAG |
miR-216 | 1829 | 1835 | 1A | hsa-miR-216 | UAAUCUCAGCUGGCAACUGUG |
miR-219 | 1998 | 2005 | 1A,m8 | hsa-miR-219brain | UGAUUGUCCAAACGCAAUUCU |
miR-329 | 1250 | 1256 | 1A | hsa-miR-329brain | AACACACCUGGUUAACCUCUUU |
miR-363 | 2018 | 2024 | 1A | hsa-miR-363 | AUUGCACGGUAUCCAUCUGUAA |
miR-377 | 2201 | 2207 | m8 | hsa-miR-377 | AUCACACAAAGGCAACUUUUGU |
miR-448 | 1180 | 1186 | m8 | hsa-miR-448 | UUGCAUAUGUAGGAUGUCCCAU |
miR-450 | 2020 | 2026 | 1A | hsa-miR-450 | UUUUUGCGAUGUGUUCCUAAUA |
miR-503 | 2225 | 2231 | 1A | hsa-miR-503 | UAGCAGCGGGAACAGUUCUGCAG |
miR-505 | 1962 | 1968 | 1A | hsa-miR-505 | GUCAACACUUGCUGGUUUCCUC |
miR-543 | 2006 | 2012 | 1A | hsa-miR-543 | AAACAUUCGCGGUGCACUUCU |
miR-96 | 1232 | 1238 | m8 | hsa-miR-96brain | UUUGGCACUAGCACAUUUUUGC |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.